[Antihypertensive agents and anesthesia].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003000:Clonidine / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D005730:Ganglionic Blockers / Q000009:adverse effects; D006145:Guanethidine / Q000009:adverse effects; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008750:Methyldopa / Q000009:adverse effects; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010946:Plants, Medicinal; D011437:Propylamines / Q000009:adverse effects; D011926:Rauwolfia / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D011437:Propylamines; D006830:Hydralazine; D008750:Methyldopa; D003000:Clonidine; D006145:Guanethidine
Zum Problem: antihypertensiva und Anästhesie.